Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue pro forma for the acquisition of Covance in excess of $8.5 billion in 2014 and more than 48,000 employees in over 60 countries, LabCorp offers innovative solutions to healthcare stakeholders. LabCorp clients include physicians, patients and consumers, biopharmaceutical companies, government agencies, managed care organizations, hospitals, and clinical labs.
As a pioneer in genomic testing and the commercialization of new diagnostic technologies, LabCorp is one of the world's largest clinical laboratories. LabCorp offers a broad range of routine and esoteric/genomic assays, and test more than 470,000 specimens daily for over 220,000 clients nationwide. LabCorp's reputation and proven record in the area of advanced genomic testing continues to attract the leading minds and technological pioneers in the field. LabCorp maintains a network of more than 1,700 Patient Service Centers (PSCs) nationally. These sites are strategically located throughout the United States. Furthermore, LabCorp operates 35 primary laboratory facilities, serves more than 3,500 acute care hospitals, and manages or owns 20 hospital laboratories.
To learn more about Covance Drug Development, visit www.covance.com. To learn more about LabCorp and LabCorp Diagnostics, visit www.labcorp.com.
At the core of LabCorp’s approach are its specialized laboratories. Each laboratory has a distinctive, long-standing reputation for innovation and quality.
For more information, please visit www.labcorp.com